Impact of glutathione S transferases P1 (Ile105Val) variants on the risk of GSTp, phosphorylated c-Jun kinase, and P53 phenotypic expression and their implications on overall survival outcomes in non-small cell lung cancer patients treated with chemotherapy

基因型 GSTP1公司 基因分型 生物 相关性 表型 内科学 分子生物学 医学 基因 遗传学 几何学 数学
作者
Anurag Pathak,Nuzhat Husain,Saumya Shukla,Rahul Pandey,Surya Kant,Lakshmi Bala
出处
期刊:Mutation Research: Fundamental And Molecular Mechanisms Of Mutagenesis [Elsevier BV]
卷期号:824: 111775-111775 被引量:2
标识
DOI:10.1016/j.mrfmmm.2022.111775
摘要

This study focused on GST-M1, T1 null, and P1 Ile105Val variant genotypes associated with the risk of altered expression of GSTp, pJNK, and P53 in NSCLC patients. These markers and overall survival (OS) were correlated with a key set of clinicopathological characteristics.Genotyping of GST- M1, T1 (+/-), and P1 (Ile105Val) was performed using PCR-RFLP.The expression of GSTp, pJNK, and P53 phenotypes was assessed by immunohistochemistry. The Spearman test was used to examine the correlation between GSTp, pJNK, and P53. Kaplan-Meier test was used for OS analysis.GSTP1 Val/Val and Ile/Val genotypes notably increased GSTp expression by 1.8 and 1.7 fold, respectively (p = 0.04,p = 0.06). GSTP1 Val/Val and Ile/Val genotypes considerably reduced P53 expression by 0.61 and 0.57 fold, respectively (p = 0.03& p = 0.05), respectively. GSTp, pJNK, and P53 were significantly co-expressed (p < 0.001). GSTp and pJNK expression showed a moderate negative correlation (ρ = -0.32, p = 0.046). In contrast, GSTp and P53 expression exhibited a strong negative correlation (ρ = -0.53, p < 0.0001). There was no correlation between P53 and pJNK expression(ρ = 0.07, p = 0.54). The patient's median OS was 8.9 months, and it was significantly related to pack-years, stage, metastasis, and GSTM1(-/-) genotypes (p > 0.05). SQCLC showed poor OS than ADC (5.7 months vs.9.1 months, p = 0.2). Stage IV and metastasis significantly reduced the OS (p = 0.001). The tumour size and lymph nodes reflected poor OS (p = 0.07&p = 0.06). Gemcitabine+Cisplatin and Gefitinib showed a slightly higher rate of survival (9.3 months and 8.1 months) than Pemtrexe+Cisplatin treatment (7.0 months,p = 0.8). Multivariate analysis revealed that pack-years and GSTp were independent predictors for OS (p = 0.03).GSTp, pJNK, and P53 showed interconnected cascading. Age, pack-year, stage, and GSTp were found to be significant predictive factors for OS.Pack-years, GSTp independent OS predictor.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Annaya完成签到 ,获得积分10
1秒前
dgqyushen完成签到,获得积分10
1秒前
ning完成签到 ,获得积分10
1秒前
前方的菜鸟完成签到 ,获得积分10
3秒前
ZQ完成签到 ,获得积分10
4秒前
Criminology34应助靖哥哥采纳,获得30
5秒前
7秒前
波博士完成签到,获得积分10
7秒前
8秒前
hdbys完成签到,获得积分10
9秒前
nieyy完成签到,获得积分10
11秒前
qi完成签到 ,获得积分10
12秒前
林玖再完成签到 ,获得积分10
12秒前
靖哥哥完成签到,获得积分10
14秒前
gj2221423完成签到 ,获得积分10
14秒前
redmoon完成签到,获得积分10
15秒前
哈哈哈完成签到,获得积分10
19秒前
Shaohan完成签到,获得积分10
19秒前
20秒前
震动的念波完成签到 ,获得积分10
23秒前
王继完成签到,获得积分10
24秒前
背后如之完成签到,获得积分10
24秒前
卡片完成签到,获得积分10
24秒前
想毕业的笑笑完成签到,获得积分10
24秒前
生动幼菱完成签到 ,获得积分20
24秒前
25秒前
kyokyoro完成签到,获得积分10
26秒前
胡思乱响完成签到,获得积分10
27秒前
hahaha6789y完成签到,获得积分10
27秒前
行者无疆发布了新的文献求助10
27秒前
舒心的夜完成签到,获得积分10
28秒前
愤怒的水绿完成签到,获得积分10
29秒前
想毕业的猫猫完成签到,获得积分10
29秒前
司空威完成签到,获得积分10
29秒前
Xiao_Fu完成签到,获得积分10
29秒前
wjswift完成签到,获得积分0
29秒前
spark完成签到,获得积分10
29秒前
夢隱完成签到 ,获得积分10
30秒前
友好凝荷完成签到,获得积分10
30秒前
maybe完成签到,获得积分10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Autoparametric Resonance in Mechanical Systems 1000
Effects of Two Weeks of Red Light Therapy on Choroidal Thickness and Axial Length in Young Adults 700
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 600
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
the fractional Laplacian 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7668054
求助须知:如何正确求助?哪些是违规求助? 9236700
关于积分的说明 19881054
捐赠科研通 7237256
什么是DOI,文献DOI怎么找? 3284036
关于科研通互助平台的介绍 2442942
邀请新用户注册赠送积分活动 2285554